van Houte Hans's Form 4 filing
Nurix Therapeutics, Inc. (NRIX) · filed Aug 1, 2025
- Accession no.
- 0001549595-25-000103
- Filed
- Aug 1, 2025
- Trade date
- Aug 1, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $59.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| van Houte HansCIK 0001817217 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Common Stock | SSaleDisposed | −5,402 | $11.03 | −$59,584.06 | 35,512 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.